Network pharmacology and molecular docking identify eugenol as a lead compound targeting visceral leishmaniasis pathways with nanotechnology-driven drug design and nanoscale interaction analysis. (2026). Experimental and Theoretical NANOTECHNOLOGY, 10(3), 1449-1468. https://doi.org/10.56053/10.3.1449